Neurology and Neurosurgery

Host: Ryan Quigley Guest: Lyn R. Griffiths Decades of research have transformed our understanding of migraine genetics, from rare monogenic types to complex polygenic forms. Mr. Ryan Quigley is joined by Dr. Lyn Griffiths to explore polygenic risk scores, emerging diagnostic tools, and the promise of personalized medicine in migraine care. Dr. Griffiths is a Distinguished Professor and the Director of the Centre for Genomics and Personalised Health at Queensland University of Technology in Brisbane, Australia.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Rashmi B. Halker Singh, M.D. Stigma and misconceptions around migraine can lead to misdiagnosis, undertreatment, and inequitable care, especially in emergency and primary care settings. Listening to patients, validating lived experiences, and enhancing clinical training to recognize migraine as a complex neurologic disorder can help shift the narrative. Learn more as Dr. Charles Turck speaks with Dr. Rashmi Halker Singh about how we can prioritize inclusive, informed, and effective migraine management. Dr. Halker Singh is a Professor of Neurology, and she sits on the Executive Board of Directors at the American Headache Society.

A secondary analysis of eight clinical trials assessed the efficacy of ubrogepant and atogepant in both acute and preventive migraine treatments. Dive into these findings and explore implications for the future of migraine care.

Guest: Andrew G. Lee, MD Host: Ashley Baker, MSN, PMHNP Tailored, team-based care is essential for optimal outcomes in patients with chronic inflammatory demyelinating polyneuropathy (CIDP). Ashley Baker sits down with Dr. Andrew Lee to learn more about the diagnostic complexities of the disease, the critical role of neuro-opthalmology, and the importance of shared decision making in creating individualized care plans.

Guest: John Golden Guest: Michael Greenberg, MD EEG-guided headphones from Vital Neuro present a new frontier in anxiety management through personalized, real-time neurofeedback and music therapy. Dr. Michael Greenberg speaks with Vital Neuro CEO John Golden about the science behind these devices, their effectiveness in reducing anxiety symptoms, and how they can integrate into daily life.

Guest: John Golden Host: Michael Greenberg, MD Neuro-responsive EEG headphones are helping healthcare professionals combat burnout by promoting calm, focus, and resilience. Backed by neuroscience and real-time brain monitoring, this personalized technology blends music and neurofeedback to optimize mental states and reduce stress. Hear from Vital Neuro CEO John Golden as he joins Dr. Michael Greenberg to discuss this device's impact in clinical workflows, from pre-op anxiety management to enhanced physician well-being.

Guest: Nicolas Dubuisson, MD Host: Ryan Quigley Early recognition of CIDP is essential to prevent irreversible damage and guide appropriate treatment, but its varied presentations can complicate diagnosis. Ryan Quigley sits down with Dr. Nicolas Dubuisson to discuss the clinical hallmarks of CIDP, its variants, and key risk factors. Dr. Dubuisson is a Postdoctoral Researcher at the Nuffield Department of Clinical Neurosciences at Oxford University in England.

Guest: Chafic Karam, MD Host: Ryan Quigley Treatment options for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) are rapidly advancing, with new approaches reshaping clinical decision-making. In this expert-led discussion, Mr. Ryan Quigley speaks with Dr. Chafic Karam, Professor of Clinical Neurology and Chief of the Neuromuscular Division at the University of Pennsylvania, about the latest FDA-approved therapies—including subcutaneous immunoglobulin and efgartigimod—and the promise of complement inhibition therapies in ongoing trials.

Guest: Danielle Minetti Host: Ryan Quigley Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) presents unique challenges for newly diagnosed patients and their caregivers. Meeting patients where they are, identifying common misconceptions, and providing effective and individualized education can go a long way in creating an engaging management plan. Mr. Ryan Quigley sits down with Ms. Danielle Minetti to learn more about actionable approaches to support informed and empowered decision-making across the care continuum. Ms. Minetti is a clinical nurse educator and the creator of Lucid Med, an online platform focusing on chronic illness education.

Host: Alejandro A. Rabinstein, MD, FAHA Guest: Richard E. Pratley, MD Guest: Jay H. Shubrook, DO, FACOFP, FAAFP Listen to expert faculty discuss the role of GLP-1RAs in reducing stroke risk for patients with type 2 diabetes in this on-demand webcast with accompanying slides

Guest: John A. Morren, MD, FAAN, FAANEM The symptom variability, prolonged asymptomatic periods, and inconsistent presentations of generalized myasthenia gravis (gMG) often lead to significant diagnostic delays and misdiagnoses. Based on recent studies, these delays then correlate with increased disease severity, longer time to symptom control, and worsened quality of life. Here to help uncover the hidden toll of diagnostic delays on patients with gMG is Dr. John Morren. He’s the Program Director of the Neuromuscular Medicine Fellowship at Cleveland Clinic and an Associate Professor of Neurology at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.

Guest: Riley Bove, MD, MMSc Many patients with multiple sclerosis (MS) experience neurogenic bladder symptoms—ranging from urgency and incontinence to retention and infection risk—but these issues are often underprioritized in care. Based on recent research, remote, commercially available bladder monitoring tools can help address this unmet need and uncover day-to-day fluctuations in bladder function. To learn more about this research, tune in to hear from Dr. Riley Bove. Not only is Dr. Bove a practicing neurologist and clinician scientist in the UCSF Weill Institute for Neurosciences, but she also presented a session on this exact topic at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting.

Guest: Riley Bove, MD, MMSc From pregnancy planning and postpartum relapse risk to the overlapping symptoms of menopause, women with multiple sclerosis (MS) face unique challenges throughout the reproductive lifespan. Here to share key takeaways from her session at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting that focused on how we can better care for these patients is Dr. Riley Bove, a practicing neurologist and clinician scientist in the UCSF Weill Institute for Neurosciences.

Host: Jerome Lisk, MD, MBA, M.S., FAAN Guest: Emile Maamary Guest: Mark Elias For patients with who struggle with daily activities due to Parkinson's disease or essential tremor, treatment options are mostly limited to medication and invasive surgery. That's why Steadiwear co-founders Mark Elias and Emile Maamary developed an FDA-registered glove engineered to suppress hand tremors. Dr. Jerome Lisk sits down with Mr. Elias and Mr. Maamary to learn more about the device and its potential real-world impacts.

Host: Crystal Proud, MD Guest: John Brandsema, MD Guest: Omer Abdul Hamid, MD Explore the latest treatment options, age-specific management strategies, and clinical trial data for patients with Duchenne muscular dystrophy (DMD). Through expert-led discussions and real-world patient cases, you’ll gain practical insights to help you confidently navigate today’s ever-evolving treatment landscape and deliver personalized, informed care.

Guest: Rosaline Quinlivan From sustained therapy and emergency planning to psychological support, coordinated care is essential as patients with Duchenne muscular dystrophy (DMD) transition into adulthood. Explore multidisciplinary approaches to optimize function, independence, and quality of life in adults with DMD with Dr. Rosaline Quinlivan, Professor of Neuromuscular Disease at University College London.

Guest: Rosaline Quinlivan As patients with Duchenne muscular dystrophy (DMD) transition from pediatric to adult care, they may encounter healthcare professionals—from primary care to emergency medicine—without prior experience managing their condition. Explore critical gaps in adult services for DMD and gain practical insights to help deliver timely, informed, and compassionate care with Dr. Rosaline Quinlivan, Professor of Neuromuscular Disease at University College London.

Host: Vera Bril, MD Guest: Neelam Goyal, MD Traditional therapies for generalized myasthenia gravis (gMG) have proven beneficial for many patients in the short term but often come with unacceptable side effects. The emergence of targeted inhibitors of the neonatal Fc receptor (FcRn) has created a groundbreaking paradigm shift in our approach to both the short- and longer-term management of affected patients. Join Drs. Vera Bril and Neelam Goyal as they take a deep dive into this topic and discuss how FcRn inhibitors are changing the therapeutic landscape of gMG.

Guest: Andrew J. Solomon, MD Accurately diagnosing multiple sclerosis (MS) involves understanding the diagnostic criteria, recognizing red flags to avoid misdiagnosis, and keeping up with new tools. Dr. Andrew Solomon, Professor and Interim Chair of the Department of Neurological Sciences and Chief of the Multiple Sclerosis Division at the University of Vermont, walks through the most difficult aspects of diagnosing patients with MS and potential breakthroughs reshaping how we approach these challenges. Dr. Solomon also spoke about this topic at the 2025 American Academy of Neurology Annual Meeting.

Guest: Karissa Gable, MD From innovative diagnostic strategies to targeted immunotherapies, our approach to chronic inflammatory demyelinating polyneuropathy (CIDP) management is rapidly evolving. Dr. Karissa Gable, Assistant Professor of Neurology at Duke University Medical Center, breaks down the new developments that aim to improve outcomes through a deeper pathophysiological understanding of the disease and personalized strategies.